If you're looking for the Minnesota Organization on Fetal Alcohol Syndrome (MOFAS) you have come to the right place. We have some exciting news about our organization. We have a new name! MOFAS has officially been renamed Proof Alliance. Our mission remains the same: to prevent prenatal alcohol exposure and to improve the quality of life for people living with fetal alcohol spectrum disorders (FASD).
We now have the proof that prenatal alcohol exposure is a leading cause of brain injury in children. We have the proof that FASD is 100% preventable and people living with an FASD can reach 100% of their potential.
We seek to build powerful alliances with people with an FASD, their families, legislators, experts in the field, new partners, and community members to bring awareness, research, and services to this field.
Proof Alliance is rebranding, expanding, and we're moving! We have a new logo, website, and prevention campaign to help change the norms around drinking during pregnancy. And in May 2019 we will be moving to a stand-alone building. Proof Alliance commits to the people of Minnesota and we will continue to develop transformative programs to help Minnesotans impacted by FASD.
August 17, 2016
An organization of Fetal Alcohol Spectrum Disorder (FASD) experts, coordinated by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has proposed new clinical guidelines for diagnosing FASD. Updates include a new definition for prenatal alcohol exposure; a guide to evaluating facial and physical deformities; and the addition of recurrent seizures as evidence of FAS. Read more about the update here.
Dr. H Eugene Hoyme, Chief of Genetics and Genomic Medicine at Sanford Health, authored the first guidelines in 2005; he recently revised them in response to the findings of his recent study, which suggest a higher prevalence rate of FASD than anticipated. Currently, two-to-give percent of children in the U.S. show some signs of prenatal alcohol exposure.
“We’re hopeful that the improved specificity of these guidelines will help clinicians to assess FASD better, thereby leading to early intervention for affected children,” Dr. Hoyme said.
Dr. Hoyme is one of the MOFAS FASD Matters Conference keynote speakers this year. His research focuses on the delineation of mechanisms of birth defects and malformation syndromes: specifically, the adverse effects of alcohol on the developing embryo and fetus. He is part of a multi-site NIAAA funded consortium of institutions conducting international studies on the prevalence of FASD in school-age children. In the course of his research, he has personally examined 3,000 children who have been exposed alcohol in utero. He conducts global research and recently conducted a three-week research trip in South Africa, where he continues to work on prevalence, prevention, and intervention among first graders in the Western Cape. Register for the 5th Annual FASD Matters Conference and hear Dr. Hoyme’s new findings.